Literature DB >> 6295433

Therapeutic effect of acyclovir (ZoviraxTM) on the pathogenesis of chronic murine cytomegalovirus infection in the immunodeficient nude mouse.

P Carthew.   

Abstract

The ability of acyclovir (ZoviraxTM) to influence the outcome of chronic cytomegalovirus infection in the nude mouse has been studied over a period of 3 weeks. Nude mice infected with a low dose of murine cytomegalovirus develop a chronic progressive disease which is characterized by typical lesions in the lung, the liver, salivary glands and many other organs. After 18-21 days most nude mice die of pneumonia and hepatitis. When acyclovir (ZoviraxTM) was administered s.c. twice daily, starting 1 day after the infectious dose of virus, a marked improvement was noted. No nude mice given the drug died in the 21-day period and the number of lesions to the lung, liver and salivary glands was reduced quantitatively by a highly significant amount.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295433      PMCID: PMC2040705     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  18 in total

1.  Replication of mouse cytomegalovirus in thymidine kinase-deficient mouse cells.

Authors:  Y Eizuru; Y Minamishima; A Hirano; T Kurimura
Journal:  Microbiol Immunol       Date:  1978       Impact factor: 1.955

Review 2.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Splenic necrosis in mice infected with cytomegalovirus.

Authors:  C A Mims; J Gould
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

4.  Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.

Authors:  E R Kern; G A Olsen; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

5.  The in vitro activity of acyclovir and related compounds against cytomegalovirus infections.

Authors:  A S Tyms; E M Scamans; H M Naim
Journal:  J Antimicrob Chemother       Date:  1981-07       Impact factor: 5.790

6.  Thymidine kinase activity in mouse embryo fibroblast cells infected with murine cytomegalovirus.

Authors:  H M Naim; A S Tyms
Journal:  Biochem Biophys Res Commun       Date:  1981-04-15       Impact factor: 3.575

7.  Parenteral acyclovir therapy for herpesvirus infections in man.

Authors:  P J Selby; R L Powles; B Janeson; H E Kay; J G Watson; R Thornton; G Morgenstern; H M Clink; T J McElwain; H G Prentice; R Corringharn; M G Ross; A V Hoffbrand; D Brigden
Journal:  Lancet       Date:  1979-12-15       Impact factor: 79.321

8.  Thymidine-kinase in cytomegalovirus infected cells.

Authors:  V Závada; V Erban; D Rezácová; V Vonka
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

9.  Mouse cytomegalovirus. Necrosis of infected and morphologically normal submaxillary gland acinar cells during termination of chronic infection.

Authors:  D Henson; A J Strano
Journal:  Am J Pathol       Date:  1972-07       Impact factor: 4.307

10.  Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers.

Authors:  B R Jones; D J Coster; P N Fison; G M Thompson; L M Cobo; M G Falcon
Journal:  Lancet       Date:  1979-02-03       Impact factor: 79.321

View more
  3 in total

1.  Modification of acute murine cytomegalovirus adrenal gland infection by adoptive spleen cell transfer.

Authors:  J D Shanley
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

2.  Murine cytomegalovirus adrenalitis in athymic nude mice.

Authors:  J D Shanley; E L Pesanti
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

3.  Histopathological characterization of the naturally occurring hepatotropic virus infections of nude mice.

Authors:  P Carthew
Journal:  J Pathol       Date:  1984-01       Impact factor: 7.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.